Last week, I had the opportunity to perform my first surgery using the Toumai robotic surgical platform developed by MedBot – one of the earliest installations of this technology in India. As surgeons, we constantly witness the evolution of technology, and it is important that we harness these advances for the benefit of our patients.

For my first case, I performed a robotic total thyroidectomy. Admittedly, thyroid surgery would not have been my first choice when operating for the first time on a completely new robotic platform. Robotic head and neck surgery is a niche in itself, and for most robotic surgical oncologists, surgical volumes are higher for abdominal, pelvic, and thoracic procedures. Undertaking such a procedure on a new robotic system presents both a challenge and an opportunity to evaluate its true capabilities.

However, the experience proved to be remarkably reassuring. From a surgical perspective, I was quite impressed with the platform’s quality of visualization, precise instrument articulation, and intuitive console control. The ergonomic design enabled confident dissection around critical structures such as the recurrent and external laryngeal nerves, as well as safe preservation of the parathyroid glands.

The introduction of new robotic platforms into the Indian healthcare ecosystem represents more than technological advancement – it signals a shift toward greater accessibility, innovation, and competition in surgical robotics. As early adopters, surgeons play a critical role in evaluating these systems, defining best practices, ensuring patient safety, and generating evidence that guides responsible integration into clinical care.

Being part of this early phase is both a privilege and a responsibility. As we gain experience and refine techniques, our collective goal must remain clear: to harness innovation in ways that meaningfully improve patient care and advance the future of surgical oncology and robotic surgery in India.